- Gecina adjusted its full-year recurrent net per share forecast to a range of €6.65 to €6.70, narrowing from the previous range of €6.60 to €6.70 with an overall estimate at €6.65.
- The recurrent net per share is anticipated to increase by 3.6% to 4.4%, compared to the previous expectation of 2.8% to 4.4% growth.
- For the first half of the year, recurring net income reached €250.4 million, marking a 6.5% increase year-over-year. This surpassed the estimated €231.5 million.
- The recurrent net per share for the first half was €3.38, compared to €3.18 in the same period last year, and above the estimated €3.18.
- Gross rental income achieved €359.9 million, showing a 4.9% rise year-over-year, outperforming the estimate of €350.7 million.
- Net rental income stood at €330.4 million, reflecting a growth of 5.5% year-over-year.
- Market analysts have provided 14 buy recommendations, 2 hold recommendations, and 3 sell recommendations for Gecina.
A look at Gecina SA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 4.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
With top scores across Value, Dividend, and Growth factors, Gecina SA shows a promising long-term outlook. As a real estate investment company focused on commercial and residential properties in France, Gecina’s robust financial position and high dividend yield make it an attractive choice for investors seeking stable returns.
While the company has slightly lower scores in Resilience and Momentum, its strategic focus on rental properties and diverse client base comprising international businesses positions Gecina well for sustained growth in the real estate market. Overall, Gecina SA‘s strong performance across key factors bodes well for its future prospects as a solid investment option.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
